Recent Changes to CBD Regulations: What You Need to Know.
Cannabis
Services
Unlocking the Benefits of Medicinal Cannabis and CBD
With over 15 years of analytical testing experience, we have expanded our services to include validated methods for cannabis-based products and cannabidiol (CBD) to ensure quality, safety, and efficacy.
Cannabis Analytical Testing
From high-quality sample handling to state-of-the-art GMP compliant testing facilities and expert scientific insight into test results, your medicinal cannabis or CBD project will be supported by scientific experts with years of analytical testing experience. Our scientists will be on hand every step of the way to ensure you understand the data and can make the best decisions throughout your cannabis or CBD product development or regulatory compliance project. All communication will be proactive, timely, and from a subject matter expert that understands your business needs, helping accelerate your project timelines and build trust.
.png "CIC Logo (1)")
Cannabinoid Services Resources
Learn more about we can help bring your medicinal cannabis and CBD product to market high-quality analytical testing integrated with expertise in scientific strategy and an understanding of global regulatory pathways.
Whitepaper: Does CBD Really Harm the Liver?
Both the FDA and EFSA have raised several concerns about CBD as supplements and as an ingredient in food and drinks, citing potential liver damage as a possible side effect. Is CBD really that toxic to the liver? To find out, toxicologist Cristelle Santos looks at the scientific evidence.
Cannabis Services
Enhancing the positive reputation of cannabis by accelerating safe, efficacious, and high-quality cannabis products to a regulated market. Learn more about our cannabis services.
Whitepaper: A Summary of the Legal Status and Regulatory Pathways to Market for Cannabinoid Products in the UK Market
Broughton summarises the regulatory pathways available for cannabinoid products in the UK market and the legal requirements for each potential market route.
Whitepaper: Review of the degradation pathways of cannabinoids, the potential impact on medicinal and consumer products, and discussion of mitigation solutions
In this whitepaper, Broughton discusses the susceptibility of cannabinoids to degrade and summarizes the main degradation pathways of the primary cannabinoid products on the market; tetrahydrocannabinol (THC) and Cannabidiol (CBD).
Whitepaper: The importance of the human endocannabinoid system when developing therapeutic cannabis products
To develop cannabis products that can both enhance the quality of life of cannabis users and comply with current and future regulations, we believe that fi rst we need to understand what cannabis is, how people use it, and how it affects the human body and mind. This white paper aims to provide essential but concise information about these areas, supported by scientific evidence.
Medicinal Cannabis and CBD Services
Learn more about our UK and EU Novel Food Application scientific consultancy and analytical testing support.Arrange a meeting with a scientific or regulatory expert to discuss your project and learn how we can help accelerate your product to market to maximize your success.
~ Advancing industry standards through collaboration ~.
The medical cannabis industry is rapidly expanding, with increasing regulatory scrutiny ensuring that products meet quality, safety, and efficacy ....